Mahvash disease
Mahvash disease is a rare genetic disorder characterized by pancreatic neuroendocrine tumors (PNETs) and hyperinsulinemia. It is named after the researcher who first described the condition. The disease is caused by mutations in the glucagon receptor (GCGR) gene, which leads to the development of tumors in the pancreas and an overproduction of insulin.
Presentation
Patients with Mahvash disease typically present with symptoms related to hypoglycemia, such as dizziness, sweating, confusion, and seizures. These symptoms are due to the excessive production of insulin by the pancreatic tumors. The tumors are usually benign but can cause significant clinical problems due to their hormonal activity.
Genetics
Mahvash disease is inherited in an autosomal recessive manner. This means that an individual must inherit two copies of the mutated gene, one from each parent, to develop the disease. The GCGR gene is responsible for encoding the glucagon receptor, which plays a crucial role in glucose metabolism. Mutations in this gene disrupt normal glucose homeostasis, leading to the clinical manifestations of the disease.
Diagnosis
The diagnosis of Mahvash disease is based on clinical presentation, biochemical tests showing hyperinsulinemia, and genetic testing confirming mutations in the GCGR gene. Imaging studies such as CT scan or MRI may be used to identify pancreatic tumors.
Treatment
The primary treatment for Mahvash disease involves managing hypoglycemia and may include dietary modifications, medications to reduce insulin secretion, and surgical removal of pancreatic tumors. In some cases, pancreatectomy may be necessary to control symptoms.
Prognosis
The prognosis for individuals with Mahvash disease varies depending on the severity of the condition and the effectiveness of treatment. With appropriate management, many patients can lead relatively normal lives, although they may require ongoing medical care to monitor and manage their condition.
Related Pages
- Pancreatic neuroendocrine tumor
- Hyperinsulinemia
- Hypoglycemia
- Glucagon receptor
- Genetic disorder
- Autosomal recessive
Categories

This article is a genetic disorder stub. You can help WikiMD by expanding it!
-
Mahvash disease
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian